News
Position ：
- Vebreltinib Enteric Capsules approved with conditions for marketing by China NMPA2023-12-22
- Xianglei Tangzu Cream approved with conditions for marketing by China NMPA2023-12-22
- 14th China International Medical Device Regulatory Forum Notification(First Roound)2023-12-07
- Letter by GHWP Chair Dr. Xu Jinghe2023-12-06
- 27th Annual Meeting of GHWP held in Shanghai2023-12-04
- GHWP constantly deepens bilateral dialogues2023-12-04
- The 27th GHWP TC Meeting successfully held2023-12-04
- GHWP Capacity Building successfully held2023-12-04
- GHWP actively promotes diverse international exchange and cooperation2023-12-04
- Major progress in drug review and evaluation in 20222023-11-15